A closer look at the technologies used by Stelara
Stelara
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.stelarainfo.comRevenue
$10.1 MillionIndustry
About Stelara
DARZALEX® and DARZALEX FASPRO® are treatments for multiple myeloma, designed for both newly diagnosed and previously treated patients. The products include the latest FDA-approved quad treatment combination for individuals who are not eligible for stem cell transplants. The company provides resources and support for patients and healthcare professionals, including treatment information and patient stories. Their primary clients are patients diagnosed with multiple myeloma and healthcare providers in the United States.Explore more
SIC Code 28,283NAICS Code 32,325Show moreStelara Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Stelara
Sign Up For FreeTo access detailed company insights
DARZALEX® and DARZALEX FASPRO® are treatments for multiple myeloma, designed for both newly diagnosed and previously treated patients. The products include the latest FDA-approved quad treatment combination for individuals who are not eligible for stem cell transplants. The company provides resources and support for patients and healthcare professi... Read More